Movatterモバイル変換
[0]
ホーム
URL:
画像なし
夜間モード
Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Community portal
Project chat
Create a new Item
Recent changes
Random Item
Query Service
Nearby
Help
Special pages
Lexicographical data
Create a new Lexeme
Recent changes
Random Lexeme
Search
Search
English
Appearance
Donate
Create account
Log in
Personal tools
Donate
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
propranolol
(Q423364)
Item
Discussion
English
Read
View history
Tools
Tools
move to sidebar
hide
Actions
Read
View history
General
What links here
Related changes
Permanent link
Page information
Concept URI
Cite this page
Get shortened URL
Download QR code
Print/export
Create a book
Download as PDF
Printable version
In other projects
Appearance
move to sidebar
hide
From Wikidata
beta blocker drug
propranolol hydrochloride
Propanolol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
beta-Propranolol
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
Propanalol
Euprovasin
[2-hydroxy-3-(naphthalen-1-yloxy)propyl](propan-2-yl)amine
Propanix
Dociton
b-Propranolol
Propranololum
β-Propranolol
Bedranol
Inderal
Hemangeol
edit
Language
Label
Description
Also known as
default for all languages
No label defined
–
English
propranolol
beta blocker drug
propranolol hydrochloride
Propanolol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
beta-Propranolol
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
Propanalol
Euprovasin
[2-hydroxy-3-(naphthalen-1-yloxy)propyl](propan-2-yl)amine
Propanix
Dociton
b-Propranolol
Propranololum
β-Propranolol
Bedranol
Inderal
Hemangeol
Statements
instance of
group of stereoisomers
0 references
subclass of
beta blocker
0 references
essential medicine
0 references
chemical compound
0 references
chemical structure
Propranolol.svg
512 × 225; 3 KB
media legend
struktura propanololu bez wskazania stereochemii cząsteczki
(Polish)
structure of propanolol with undefined stereochemistry
(English)
0 references
mass
259.157229
dalton
1 reference
stated in
PubChem
PubChem CID
4946
language of work or name
English
title
propranolol
(English)
retrieved
3 October 2016
chemical formula
C₁₆H₂₁NO₂
1 reference
stated in
PubChem
PubChem CID
4946
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
canonical SMILES
CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
1 reference
stated in
PubChem
PubChem CID
4946
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
active ingredient in
Inderal
1 reference
stated in
RxNorm
RxNorm ID
151890
retrieved
14 February 2018
InnoPran
1 reference
stated in
RxNorm
RxNorm ID
856468
retrieved
14 February 2018
Hemangeol
1 reference
stated in
RxNorm
RxNorm ID
1495059
retrieved
14 February 2018
World Health Organisation international non-proprietary name
propranolol
(English)
1 reference
stated in
ChEBI
ChEBI ID
8499
language of work or name
English
title
propranolol
(English)
retrieved
3 October 2016
found in taxon
Asimina triloba
1 reference
stated in
Antiangiogenic Activity and Chemical Derivatization of the Neurotoxic Acetogenin Annonacin Isolated from Asimina triloba
side effect
bradycardia
1 reference
ISBN-13
978-1-259-64115-2
sleep disorder
of
infant
0 references
asthma
0 references
fatigue
0 references
Vivid dream
0 references
medical condition treated
myocardial infarction
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
arterial hypertension
2 references
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
essential tremor
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
phaeochromocytoma
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
portal hypertension
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
anxiety disorder
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
panic disorder
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
congestive heart failure
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
angina pectoris
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
ventricular fibrillation
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
supraventricular tachycardia
1 reference
stated in
NDF-RT
NDF-RT ID
N0000148001
language of work or name
English
retrieved
13 December 2016
PHACE association
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
anxiety
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
migraine
1 reference
stated in
Drug Indications Extracted from FAERS
retrieved
2 October 2018
thyroid crisis
1 reference
title
Basic and Clinical Pharmacology 14th Edition
(English)
ISBN-13
9781259641152
capillary hemangioma
0 references
significant drug interaction
bromperidol
1 reference
reference URL
https://www.drugbank.ca/drugs/DB00571
floctafenine
1 reference
reference URL
https://www.drugbank.ca/drugs/DB00571
adrenergic beta-agonists
1 reference
reference URL
https://www.drugbank.ca/drugs/DB00571
methacholine
1 reference
reference URL
https://www.drugs.com/drug-interactions/propranolol-index.html
rivastigmine
1 reference
reference URL
https://www.drugs.com/drug-interactions/propranolol-index.html
verapamil
side effect
sinus bradycardia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
amiodarone
side effect
sinus bradycardia
1 reference
sourcing circumstances
established
stated in
A reference set of clinically relevant adverse drug-drug interactions
digoxin
side effect
sinus bradycardia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
fingolimod
side effect
sinus bradycardia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
crizotinib
side effect
sinus bradycardia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
verapamil
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
haloperidol
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
diltiazem
side effect
sinus bradycardia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
clonidine
side effect
sinus bradycardia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
rivastigmine
side effect
sinus bradycardia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
(−)-selegiline
side effect
sinus bradycardia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
ergotamine
side effect
vasoconstriction
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
methyldopa
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
diltiazem
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
terazosin
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
prazosin
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
doxazosin
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
clonidine
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
moxonidine
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
lercanidipine
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
trimipramine
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
amitriptyline
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
(E/Z)-doxepin
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
fluphenazine
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
(−)-selegiline
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
imipramine
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
chlorpromazine
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
clomipramine
side effect
hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
tamsulosin
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
alfuzosin
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
diltiazem
side effect
myocardial depression
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
mefloquine
side effect
sinus bradycardia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
ergotamine
side effect
peripheral ischemia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
amiodarone
side effect
sinoatrial arrest
1 reference
sourcing circumstances
established
stated in
A reference set of clinically relevant adverse drug-drug interactions
amiodarone
side effect
atrioventricular block
1 reference
sourcing circumstances
established
stated in
A reference set of clinically relevant adverse drug-drug interactions
amiodarone
side effect
hypotension
1 reference
sourcing circumstances
established
stated in
A reference set of clinically relevant adverse drug-drug interactions
digoxin
side effect
toxicity
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
moxonidine
side effect
withdrawal hypertension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
dronedarone
side effect
sinus bradycardia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
fingolimod
side effect
decreased heart rate
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
fingolimod
side effect
shortened atrioventricular conduction time
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
fingolimod
side effect
atrioventricular block
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
disopyramide
side effect
short coagulation time
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
disopyramide
side effect
sinus bradycardia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
(RS)-propafenone
side effect
orthostatic hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
(RS)-propafenone
side effect
sinus bradycardia
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
mefloquine
side effect
abnormal electrocardiogram
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
mefloquine
side effect
pulseless electrical activity
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
trimipramine
side effect
orthostatic hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
amitriptyline
side effect
orthostatic hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
(E/Z)-doxepin
side effect
orthostatic hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
(−)-selegiline
side effect
orthostatic hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
imipramine
side effect
orthostatic hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
clomipramine
side effect
orthostatic hypotension
1 reference
sourcing circumstances
hypothetically
stated in
A reference set of clinically relevant adverse drug-drug interactions
fluvoxamine
side effect
sinus bradycardia
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
fluvoxamine
side effect
hypotension
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
haloperidol
side effect
pulseless electrical activity
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
chlorpromazine
side effect
seizure
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
chlorpromazine
side effect
sedation
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
chlorpromazine
side effect
infective psychosis
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
chlorpromazine
side effect
extrapyramidal symptoms
1 reference
sourcing circumstances
probably
stated in
A reference set of clinically relevant adverse drug-drug interactions
physically interacts with
adrenoceptor beta 2
subject has role
antagonist
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
564
language of work or name
English
retrieved
17 August 2016
Adrenergic receptor, beta 3
subject has role
antagonist
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
564
language of work or name
English
retrieved
17 August 2016
adrenoceptor beta 3
subject has role
antagonist
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
564
language of work or name
English
retrieved
17 August 2016
route of administration
oral administration
0 references
intravenous administration
0 references
legal status (medicine)
boxed warning
1 reference
reference URL
https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
title
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.
(English)
pregnancy category
Australian pregnancy category C
1 reference
imported from Wikimedia project
English Wikipedia
US pregnancy category C
1 reference
imported from Wikimedia project
English Wikipedia
LiverTox likelihood score
LiverTox toxicity likelihood category E
1 reference
stated in
LiverTox
retrieved
8 April 2021
reference URL
https://www.ncbi.nlm.nih.gov/books/n/livertox/Propranolol
last update
15 January 2017
has characteristic
bitterness
1 reference
stated in
BitterDB
subject has role
beta blocker
2 references
stated in
NDF-RT
NDF-RT ID
N0000148001
retrieved
5 March 2018
stated in
Medical Subject Headings
MeSH descriptor ID
D011433
retrieved
15 March 2018
antiarrhythmic agent
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D011433
retrieved
15 March 2018
antihypertensive drug
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D011433
retrieved
15 March 2018
vasodilator agent
1 reference
stated in
Medical Subject Headings
MeSH descriptor ID
D011433
retrieved
15 March 2018
has part(s)
carbon
0 references
different from
propanol
0 references
propyl alcohol
0 references
Commons category
Propranolol
0 references
Identifiers
NDL Authority ID
00576203
0 references
InChI
InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3
1 reference
stated in
PubChem
PubChem CID
4946
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
2 references
stated in
PubChem
PubChem CID
4946
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
stated in
ChEBI release 2020-09-01
CAS Registry Number
525-66-6
2 references
stated in
Global Substance Registration System
UNII
9Y8NXQ24VQ
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
stated in
CAS Common Chemistry
retrieved
8 April 2021
reference URL
https://commonchemistry.cas.org/detail?cas_rn=525-66-6
ChemSpider ID
4777
1 reference
stated in
ChemSpider
ChemSpider ID
4777
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
PubChem CID
4946
2 references
stated in
PubChem
PubChem CID
4946
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
matched by identifier from
InChIKey
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
Reaxys registry number
987417
1 reference
stated in
ChEBI
ChEBI ID
8499
language of work or name
English
title
propranolol
(English)
retrieved
3 October 2016
ChEBI ID
8499
mapping relation type
exact match
2 references
stated in
ChEMBL
ChEMBL ID
CHEMBL27
language of work or name
English
title
PROPRANOLOL
(English)
retrieved
19 November 2016
matched by identifier from
International Chemical Identifier
InChI
InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3
ChEMBL ID
CHEMBL27
1 reference
stated in
ChEMBL
ChEMBL ID
CHEMBL27
language of work or name
English
title
PROPRANOLOL
(English)
retrieved
19 November 2016
SureChEMBL ID
SCHEMBL3955
2 references
based on heuristic
inferred from InChIKey
matched by identifier from
InChIKey
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
SCHEMBL12264958
2 references
based on heuristic
inferred from InChIKey
matched by identifier from
InChIKey
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
UniChem compound ID
412566
1 reference
stated in
UniChem
MassBank accession ID
SM855601
0 references
MSBNK-Athens_Univ-AU110801
0 references
MSBNK-Eawag-EA017101
0 references
MSBNK-Eawag-EA017102
0 references
MSBNK-Eawag-EA017103
0 references
MSBNK-Eawag-EA017104
0 references
MSBNK-Eawag-EA017105
0 references
MSBNK-Eawag-EA017106
0 references
MSBNK-Eawag-EA017107
0 references
MSBNK-Eawag-EA017108
0 references
MSBNK-Eawag-EA017109
0 references
MSBNK-Eawag-EA017110
0 references
MSBNK-Eawag-EA017111
0 references
MSBNK-Eawag-EA017112
0 references
MSBNK-Eawag-EA017113
0 references
MSBNK-Eawag-EA017114
0 references
MSBNK-Eawag-EQ017101
0 references
MSBNK-Eawag-EQ017102
0 references
MSBNK-Eawag-EQ017103
0 references
MSBNK-Eawag-EQ017104
0 references
MSBNK-Eawag-EQ017105
0 references
MSBNK-Eawag-EQ017106
0 references
MSBNK-Keio_Univ-KO003927
0 references
MSBNK-Keio_Univ-KO003928
0 references
MSBNK-Keio_Univ-KO003929
0 references
MSBNK-Keio_Univ-KO003930
0 references
MSBNK-Keio_Univ-KO003931
0 references
MSBNK-Keio_Univ-KO009171
0 references
MSBNK-Keio_Univ-KO009172
0 references
MSBNK-Keio_Univ-KO009173
0 references
MSBNK-Keio_Univ-KO009174
0 references
MSBNK-Keio_Univ-KO009175
0 references
MSBNK-UFZ-UA006101
0 references
MSBNK-Waters-WA001110
0 references
MSBNK-Waters-WA001111
0 references
MSBNK-Waters-WA001112
0 references
MSBNK-Waters-WA001113
0 references
MSBNK-Waters-WA001114
0 references
SPLASH
splash10-0159-0910000000-d7db5bab374a7cf02fd3
0 references
splash10-03di-0090000000-057a63162f5e674c4ce6
0 references
splash10-03di-0190000000-87c354c205b94f5f06e1
0 references
splash10-0cl0-4930000000-1eecec66280a12a94b9d
0 references
splash10-0ab9-4900000000-ddd58df17ce1f65a7559
0 references
splash10-0a4i-4900000000-711c94a7c2e5c24e9e84
0 references
splash10-0a6r-3900000000-54967b29c739db5eb0d5
0 references
splash10-03di-0190000000-f4e36c8dd4e96992c94d
0 references
splash10-0830-4920000000-835447ce35e37ab07193
0 references
splash10-0ab9-5900000000-25248a6b39724a02096d
0 references
splash10-0a4i-4900000000-5663a764e73595039671
0 references
splash10-0a6r-3900000000-20d14f48fc5615796a2d
0 references
splash10-00lr-0910000000-d51a9e2266c2de91bfaa
0 references
splash10-03di-0090000000-d6c29037a12e6224fc5c
0 references
splash10-03di-3590000000-e89d2a443f5d3480df83
0 references
splash10-0avi-7900000000-073897b09869caa5bcdc
0 references
splash10-0ab9-7900000000-566e620bc2a178d2a8e7
0 references
splash10-0ab9-6900000000-21115e5f6c969e2f9e0f
0 references
splash10-0adi-5900000000-c8d935c939307db2ee51
0 references
splash10-03di-0090000000-ee9d9c871e322202a948
0 references
splash10-03di-0290000000-53507ada5020c820cd0f
0 references
splash10-0avi-5900000000-95293e6a5f843d0cc282
0 references
splash10-0ab9-9700000000-264398d3bc59c8ced5ed
0 references
splash10-0adi-9700000000-f5825268222d45a4ce95
0 references
splash10-0159-1900000000-63f0b6b57a76617acc2d
0 references
splash10-00di-9500000000-122203085c028de6cbe4
0 references
splash10-0aor-0900000000-8c16e93fb43526b3c84f
0 references
splash10-004i-0900000000-228cc85de86e4b27504a
0 references
splash10-00di-9200000000-2f102916e2fe0f6c1f4b
0 references
splash10-060r-4900000000-c1976ec4cf413372eb24
0 references
splash10-05i0-4900000000-dfc2a11c8d505e07028b
0 references
splash10-0159-0900000000-ece05c33751eecfe1c79
0 references
splash10-00lr-0900000000-cbbd556232c991733f57
0 references
splash10-03di-4590000000-aaddd1419df983db1236
0 references
splash10-0fk9-2932000000-fa245a17a643ef33a0b2
0 references
splash10-05fr-9000000000-84923a2dc3053801527a
0 references
splash10-03di-0090000000-f8c39664b694f5784865
0 references
DSSTox substance ID
DTXSID6023525
2 references
stated in
Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
matched by identifier from
InChIKey
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
DSSTOX compound identifier
DTXCID903525
0 references
LiverTox ID
Propranolol
0 references
EC number
208-378-0
1 reference
stated in
Global Substance Registration System
UNII
9Y8NXQ24VQ
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
ECHA Substance Infocard ID
100.007.618
1 reference
stated in
ECHA Substance Infocard database
ECHA Substance Infocard ID
100.007.618
retrieved
27 December 2018
title
Propranolol
(English)
quotation
CAS no.: 525-66-6
(English)
ATC code
C07AA05
1 reference
stated in
DrugBank
DrugBank ID
DB00571
language of work or name
English
title
Propranolol
(English)
publication date
17 November 2015
Guide to Pharmacology Ligand ID
564
1 reference
stated in
IUPHAR/BPS Guide to PHARMACOLOGY
Guide to Pharmacology Ligand ID
564
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
MeSH descriptor ID
D011433
subject named as
Propranolol
0 references
MeSH tree code
D02.033.100.624.698.711
0 references
D02.033.755.624.698.711
0 references
D02.092.063.624.698.711
0 references
D02.455.426.559.847.638.945
0 references
D04.615.638.945
0 references
RxNorm ID
8787
1 reference
stated in
Global Substance Registration System
UNII
9Y8NXQ24VQ
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
DrugBank ID
DB00571
1 reference
matched by identifier from
InChIKey
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
Human Metabolome Database ID
HMDB0001849
2 references
based on heuristic
inferred from InChIKey
matched by identifier from
InChIKey
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
UNII
9Y8NXQ24VQ
2 references
stated in
Global Substance Registration System
UNII
9Y8NXQ24VQ
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
matched by identifier from
InChIKey
InChIKey
AQHHHDLHHXJYJD-UHFFFAOYSA-N
MedlinePlus drug identifier
a682607
route of administration
oral administration
medical condition treated
cardiovascular disease
0 references
a615024
route of administration
oral administration
medical condition treated
infantile hemangioma
0 references
PatientsLikeMe treatment ID
propranolol
0 references
NDF-RT ID
N0000148001
1 reference
stated in
Global Substance Registration System
UNII
9Y8NXQ24VQ
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
Probes And Drugs ID
PD009912
0 references
DrugCentral ID
2303
1 reference
stated in
UniChem
KEGG ID
C07407
1 reference
stated in
ChEBI
ChEBI ID
8499
language of work or name
English
title
propranolol
(English)
retrieved
3 October 2016
D08443
1 reference
stated in
ChEBI
ChEBI ID
8499
language of work or name
English
title
propranolol
(English)
retrieved
3 October 2016
De Agostini ID
propranolòlo
subject named as
propranolòlo
0 references
electronic Essential Medicines List medicine ID
392
0 references
Encyclopædia Britannica Online ID
science/propranolol
subject named as
propranolol
0 references
Freebase ID
/m/019dfq
1 reference
stated in
Freebase Data Dumps
publication date
28 October 2013
KBpedia ID
Propranolol
1 reference
stated in
KBpedia
retrieved
9 July 2020
Microsoft Academic ID
2778151854
0 references
NALT ID
7821
0 references
NE.se ID
propranolol
0 references
OpenAlex ID
C2778151854
1 reference
stated in
OpenAlex
retrieved
26 January 2022
reference URL
https://docs.openalex.org/download-snapshot/snapshot-data-format
C2909915070
1 reference
stated in
OpenAlex
retrieved
26 January 2022
reference URL
https://docs.openalex.org/download-snapshot/snapshot-data-format
Quora topic ID
Propranolol
1 reference
stated in
Quora
UK Parliament thesaurus ID
439271
subject named as
Propranolol
0 references
UMLS CUI
C0033497
1 reference
stated in
Global Substance Registration System
UNII
9Y8NXQ24VQ
language of work or name
English
title
propranolol
(English)
retrieved
19 November 2016
WikiProjectMed ID
Propranolol
0 references
Sitelinks
Wikipedia
(40 entries)
edit
afwiki
Propranolol
arwiki
بروبرانولول
azbwiki
پروپرانولول
bgwiki
Пропранолол
bnwiki
প্রোপ্রানোলল
bswiki
Propranolol
cawiki
Propranolol
cywiki
Propranolol
dewiki
Propranolol
elwiki
Προπρανολόλη
enwiki
Propranolol
eswiki
Propranolol
fawiki
پروپرانولول
fiwiki
Propranololi
frwiki
Propranolol
hewiki
פרופראנולול
hrwiki
Propranolol
huwiki
Propranolol
hywiki
Պրոպրանոլոլ
idwiki
Propranolol
itwiki
Propranololo
jawiki
プロプラノロール
kowiki
프로프라놀롤
kswiki
پروپرینولول
ltwiki
Propranololis
nlwiki
Propranolol
orwiki
ପ୍ରୋପ୍ରାନୋଲୋଲ୍
pamwiki
Propranolol
plwiki
Propranolol
ptwiki
Propranolol
rowiki
Propranolol
ruwiki
Пропранолол
shwiki
Propranolol
srwiki
Propranolol
svwiki
Propranolol
thwiki
โพรพาโนลอล
trwiki
Propranolol
ukwiki
Пропранолол
viwiki
Propranolol
zhwiki
普萘洛尔
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(1 entry)
edit
commonswiki
Category:Propranolol
Retrieved from "
https://www.wikidata.org/w/index.php?title=Q423364&oldid=2305865959
"
Search
Search
propranolol
(Q423364)
Add topic
[8]
ページ先頭
©2009-2025
Movatter.jp